全文获取类型
收费全文 | 20182篇 |
免费 | 1750篇 |
国内免费 | 477篇 |
专业分类
耳鼻咽喉 | 444篇 |
儿科学 | 522篇 |
妇产科学 | 400篇 |
基础医学 | 1355篇 |
口腔科学 | 207篇 |
临床医学 | 2405篇 |
内科学 | 4037篇 |
皮肤病学 | 253篇 |
神经病学 | 1995篇 |
特种医学 | 383篇 |
外国民族医学 | 2篇 |
外科学 | 4328篇 |
综合类 | 2223篇 |
预防医学 | 908篇 |
眼科学 | 360篇 |
药学 | 1559篇 |
11篇 | |
中国医学 | 692篇 |
肿瘤学 | 325篇 |
出版年
2024年 | 72篇 |
2023年 | 441篇 |
2022年 | 792篇 |
2021年 | 1206篇 |
2020年 | 1022篇 |
2019年 | 917篇 |
2018年 | 906篇 |
2017年 | 899篇 |
2016年 | 863篇 |
2015年 | 830篇 |
2014年 | 1431篇 |
2013年 | 1527篇 |
2012年 | 980篇 |
2011年 | 1134篇 |
2010年 | 909篇 |
2009年 | 965篇 |
2008年 | 945篇 |
2007年 | 840篇 |
2006年 | 892篇 |
2005年 | 721篇 |
2004年 | 590篇 |
2003年 | 534篇 |
2002年 | 389篇 |
2001年 | 344篇 |
2000年 | 279篇 |
1999年 | 235篇 |
1998年 | 154篇 |
1997年 | 158篇 |
1996年 | 142篇 |
1995年 | 107篇 |
1994年 | 119篇 |
1993年 | 71篇 |
1992年 | 90篇 |
1991年 | 78篇 |
1990年 | 77篇 |
1989年 | 67篇 |
1988年 | 72篇 |
1987年 | 60篇 |
1986年 | 63篇 |
1985年 | 52篇 |
1984年 | 64篇 |
1983年 | 47篇 |
1982年 | 54篇 |
1981年 | 46篇 |
1980年 | 67篇 |
1979年 | 34篇 |
1978年 | 28篇 |
1977年 | 22篇 |
1976年 | 17篇 |
1974年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
背景 术后认知功能障碍(postoperative cognitive dysfunction,POCD)是一种常见的围术期并发症.γ-氨基丁酸A型(γ-aminobutyricacid type A,GABAA)受体作为一种中枢神经抑制性受体,可能对POCD的发生起着关键性作用.目的 综述以GABAA受体为靶点的相关药物对POCD的影响.内容 与GABAA受体相关的3类药物:激动剂、拮抗剂和反向激动剂,对POCD可分别产生诱发、逆转和改善症状的作用. 趋向 对记忆或者认知功能损害具有改善作用的GABAA受体相关药物,对POCD的治疗具有重大意义,将成为今后POCD的研究热点. 相似文献
122.
王新颖 《中华胃肠外科杂志》2013,(11):1031-1034
各种原因引起的肝功能障碍都会导致多种营养素代谢紊乱,进而引发营养不良.而营养不良又会影响肝功能的恢复。临床上胃肠手术患者常合并营养不良,尤合并肝功能障碍的胃肠手术患者其营养代谢明显异常。改善合并肝功能障碍胃肠手术患者的营养状态对提高手术成功率和改善预后起着重要作用。本文对合并肝功能障碍胃肠手术患者的营养支持治疗作一阐述,为其营养支持治疗提供参考。 相似文献
123.
There are various changes in the thyroid gland and its function in chronic renal failure (CRF). These changes include lower levels of circulating thyroid hormone, altered peripheral hormone metabolism, decreased binding to carrier proteins, possible reduction in tissue hormone content, and increased iodine storage in the thyroid gland. The decrease of excretion of urinary iodine in CRF increases serum inorganic iodine level and iodine content of the thyroid, which consequently enlarges the gland. This study is designed to investigate the prevalence of goiter and thyroid dysfunction in patients with end-stage renal disease (ESRD) on hemodialysis (HD) in an iodine-deficient community. Eighty-seven (40 females and 47 males) HD patients and 169 (79 females and 90 males) healthy individuals as controls are included. Sex ratios for the patient and control groups are 0.85 and 0.88, respectively. Mean ages for the patient and control groups are 42.94 +/- 11.88 and 40.20 +/- 10.72 years, respectively. Examination of the thyroid gland using ultrasonography along with simultaneous measurement of blood levels of free-T4 (FT4), free-T3 (FT3), and thyrotropin (TSH) are made for every individual. The presence of goiter demonstrable by ultrasonography is found in 32.2% of the uremic patients and in 23.5% of the controls and its prevalence increases with age (P = 0.01). In 32 (36.8%) of the patients and 29 (17.1%) of the controls at least one thyroid nodule is found in ultrasonography. Between patients with or without a nodular goiter the authors could not observe any difference for duration of dialysis and serum levels of TSH, FT4, FT3, calcium, and albumin. In ESRD patients the prevalence of nodular goiter is higher for females (47.5% vs. 27.7%, P = 0.045) and increases with age (P = 0.04). Though incidence of hyperthyroidism is found to be similar for the two groups (1.14% in ESRD patients vs. 1.10% in controls), hypothyroidism is observed in 3.4% of ESRD patients but only 0.6% of controls. This high incidence of hypothyroidism and nodular goiter in ESRD patients shows that screening for thyroid dysfunction and goiter, using appropriate laboratory tests and ultrasonography, should be considered in evaluation of every ESRD patient. 相似文献
124.
125.
在过去十年中全球预期寿命大幅增加,与年龄相关性疾病对社会和卫生保健系统造成的挑战愈演愈烈.脑小血管疾病(cerebral small vessel disease,CSVD)是一种增龄性脑微血管病变,其患病率随年龄增长而增加,在50~90岁人群中患病率由5%升至几乎100%,是导致卒中和血管性痴呆的重要血管因素,并与步... 相似文献
126.
127.
Hugo W. Huisman Aletta E. Schutte Johannes M. van Rooyen Rudolph Schutte Leoné Malan Catatharina M.T. Fourie 《Clinical and experimental hypertension (New York, N.Y. : 1993)》2013,35(1):1-15
Epidemiologic Survillance of Cardiovascular Disease Mollar G, Cavalieri L, Galarza C, Waisman G, Beratarrechea A, Petrlik E, Langlois E, Soriano F, Marchetti M, and Gonzalez B de Quirós F Programas Médicos de Plan de Salud del Hospital Italiano de Buenos AiresTo enhance efficacy of health care, surveillance activities are required, especially with chronic prevalent diseases. Epidemiologic surveillance allows US to quantify and qualify health problems, settle priorities, identify high risk groups, manage and monitor health care systems, detect frequency changes in events, and assess performance of prevention and disease management programs. We have developed a surveillance system that identifies and reports daily on patients having cardiovascular disease (CVD) who are uncontrolled.Objective: To evaluate the accomplishment of blood pressure (BP) measurement in people with CVD belonging to a health care system included in an epidemiological surveillance list.Design: Cohort study between 1/1/2004 and 9/1/2004.Methods: Patients 60 years old or older identified by surveillance system during the first term of 2004, were followed up. Patients were identified as having CVD through electronic medical record using international classification for primary attention (ICPA).Patients are reported by the software system when presenting any of the following criteria: no blood pressure record during the past 6 months, blood pressure above 140/90 in the last record, and if diabetic A1C above 7.5%.The connection with the appointment system allowed us to detect previously the patient’s attendance and, 15 min before his or her medical appointment, send the patient to be examined by the executors of a chronic disease program, according to the JNC VII guidelines.The BP measurement is a common intervention to most chronic diseases because it increases cardiovascular risk, hence it is considered a process indicator of the surveillance system.Results: Of the 24,411 patients having CVD, 5506 (26%) were listed during the first term, mean age was 74 years and 65% were female. By the end of 2004, 4660 (85%) patients had blood pressure recorded with an average values of 136.76 mmHg for systolic and 77.51 for diastolic blood pressure. Blood pressure was assessed three times in average.Conclusion: Surveillance system allowed identifying of and intervening in a high proportion of patients. 相似文献
128.
Prevalence and Predictors of Left Ventricular Diastolic Dysfunction in a Hispanic Patient Population
Carlos E. Rodríguez Castro Alexander Lyapin Mithun Pattathan José Negrin Debabrata Mukherjee 《The International journal of angiology》2013,22(4):229-234
Minimal data exist on attributes of diastolic dysfunction in the Hispanic population. The purpose of this study was to evaluate the prevalence and predictors of diastolic dysfunction in a Hispanic patient population. We performed a retrospective review of 166 consecutive echocardiograms in a southwestern Texas Hospital that caters to a large Hispanic patient population. We identified all echocardiograms that met criteria for diastolic dysfunction and assessed baseline demographics and comorbidities in the cohort of Hispanic patients. A multivariate analysis was performed to identify the independent predictors of diastolic dysfunction. A total of 129 out of 166 patients (77.8%) were of Hispanic origin. Out of the 129 patients, 87 (67.4%) had some degree of diastolic dysfunction in this population suggesting a high prevalence in the study cohort. In the diastolic dysfunction group, the mean age was 64.5 ± 13.9, 37% were male and 63% female, 78% had diabetes, 85% had hypertension, and 49% had some degree of renal insufficiency (stages 3–5). A logistic multivariate analysis showed that diabetes was an independent predictor of diastolic dysfunction with odds ratio of 2.69 (95% confidence interval [CI], 1.06–6.28; p = 0.038). Similarly age (per year increase) and chronic kidney disease were independent predictors of diastolic dysfunction. We demonstrated that older age, presence of diabetes, and renal dysfunction are independent predictors of diastolic dysfunction in the Hispanic patient population. Strategies geared toward reducing diabetes and preventing renal dysfunction are likely to decrease prevalence of diastolic dysfunction and heart failure in this community. 相似文献
129.
《Clinical and experimental hypertension (New York, N.Y. : 1993)》2013,35(7):512-515
Arterial stiffness is currently the “gold standard” measure of aortic (carotid-femoral) pulse wave velocity (PWV), which is an important independent predictor of risk of developing a cardiovascular event. Gilbert’s syndrome is a congenital disorder characterized by intermittent and non-hemolytic elevation of indirect bilirubin levels due to the deficiency of the enzyme UDP-glucuronyl transferase in the liver and many prospective studies found an inverse relationship between bilirubin levels and cardiovascular events in these patients. We aimed to investigate serum bilirubin levels and arterial stiffness parameters in patients with Gilbert’s syndrome in this study. A total of 53 cases, consisting of 26 patients with a diagnosis of Gilbert’s syndrome and 27 healthy control subjects, were included in the study. Serum bilirubin levels, other routine blood chemistry, and arterial stiffness measurements were recorded. The mean ages of Gilbert’s syndrome and the control group were 31.5 ± 9.7 and 36.8 ± 11.1 years, respectively. PWV measurements were significantly lower in Gilbert syndrome patients (6.68 and 7.3 m/s in patients and controls; respectively) (P < .05). In correlation analysis in Gilbert’s syndrome patients, PWV had a significant correlation with total and indirect bilirubin levels (r = ?0.370, P = .009/r = ?0.495, P = .003, respectively). Gilbert’s syndrome patients have lower PWV measurements compared to healthy subjects, and the total and indirect bilirubin levels are also associated with PWV measurements. These findings may indicate the decreased atherosclerotic disease incidence in Gilbert’s syndrome patients. 相似文献
130.
《Xenobiotica; the fate of foreign compounds in biological systems》2013,43(5):480-488
Abstract1.?Folate, an essential micronutrient, is a critical cofactor in one-carbon metabolism. Mammals cannot synthesize folate and depend on supplementation to maintain normal levels. Low folate status may be caused by low dietary intake, poor absorption of ingested folate and alteration of folate metabolism due to genetic defects or drug interactions.2.?Folate deficiency has been linked with an increased risk of neural tube defects, cardiovascular disease, cancer and cognitive dysfunction. Most countries have established recommended intakes of folate through folic acid supplements or fortified foods. External supplementation of folate may occur as folic acid, folinic acid or 5-methyltetrahydrofolate (5-MTHF).3.?Naturally occurring 5-MTHF has important advantages over synthetic folic acid – it is well absorbed even when gastrointestinal pH is altered and its bioavailability is not affected by metabolic defects. Using 5-MTHF instead of folic acid reduces the potential for masking haematological symptoms of vitamin B12 deficiency, reduces interactions with drugs that inhibit dihydrofolate reductase and overcomes metabolic defects caused by methylenetetrahydrofolate reductase polymorphism. Use of 5-MTHF also prevents the potential negative effects of unconverted folic acid in the peripheral circulation.4.?We review the evidence for the use of 5-MTHF in preventing folate deficiency. 相似文献